期刊
PHARMACOLOGY & THERAPEUTICS
卷 164, 期 -, 页码 97-104出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2016.04.003
关键词
Dendritic cell; Tumor immunology; Immunosuppression; Emergency myelopoiesis; Tumor microenvironment
资金
- The Jayne Koskinas
- Ted Giovanis Breast Cancer Research Consortium at Wistar
- Ovarian Cancer Research Fund (OCRF) Program Project Development awards
- Irvington Institute Fellowship Program of the Cancer Research Institute
- [R01CA157664]
- [R01CA124515]
- [R01CA178687]
- [P30CA10815]
Dendritic cells (DCs) with robust immunosuppressive activity are commonly found in the microenvironment of advanced solid tumors. These innate immune cells are generically termed regulatory DCs and include various subsets such as plasmacytoid, conventional and monocyte-derived/inflammatory populations whose normal function is subverted by tumor-derived signals. This review summarizes recent findings on the nature and function of regulatory DCs, their relationship with other myeloid subsets and unique therapeutic opportunities to abrogate malignant progression through their targeting. (C) 2016 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据